On June 4, 2025, the Singapore High Court overturned its prior rejection of WazirX’s restructuring plan, enabling a revote on the amended scheme proposed by Zettai.
The revised plan submitted by Zettai aims to address regulatory concerns, allowing Zanmai Labs to manage the distribution of funds to creditors and users.
If the creditors’ vote is favorable, WazirX may resume operations and initiate reimbursements to its users in the coming weeks.
Leave a Reply